Skinbiotherapeutics PLC (LON:SBTX) a life science company focused on skin health, has been nominated as a finalist in the Life Science IPO of the Year category of the Biotech and Money 2017 Awards.
The 2017 Biotech and Money Assembly and Awards Gala Dinner celebrates the UK’s funding, finance and investment success in the life sciences sector over the past 12 months.
SkinBioTherapeutics has been nominated for its IPO in April 2017 which raised £4.5 million in funds to enable the development of its proprietary SkinBiotix® technology platform and to accelerate the clinical development of its main therapeutic candidates. The Company’s aim is to target cosmetic products, infection control and dermatological conditions.
There are a total of 12 awards and winners in each category are determined 50% by online voting and 50% by a live vote on the night of the Awards dinner on 14 September in London.